University of Bristol
The researchers at the Royal College of Surgeons Ireland recently received €1.3 million from Wellcome Trust to support the development of the blood-based test.
The researchers envisage deploying a point-of-care assay based on a fluorescent nanophotonics platform.
Rosa Biotech Raises £760K to Develop Diagnostic Biosensing Platform
The firm's CEO said it is exploring several different disease classes with technology sensitive enough to detect the faint chemical signature of chronic diseases.